Dimensional Fund Advisors
ODT

Dimensional Fund Advisors’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Dimensional Fund Advisors’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-31,605
Closed -$92K – 3566
2021
Q3 		$92K Sell
31,605
-24,282
-43% -$80.7K ﹤0.01% 3437
2021
Q2 		$195K Sell
55,887
-5,107
-8% -$17.5K ﹤0.01% 3339
2021
Q1 		$209K Buy
+60,994
New +$1.15M ﹤0.01% 3283
2020
Q3 		– Sell
-8,988
Closed -$381K – 3374
2020
Q2 		$381K Sell
8,988
-400
-4% -$12.9K ﹤0.01% 3124
2020
Q1 		$259K Hold
9,388
– – ﹤0.01% 3167
2019
Q4 		$305K Buy
+9,388
New +$291K ﹤0.01% 3212

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Dimensional Fund Advisors's ODT Position: Q4 2021 in Review

Dimensional Fund Advisors sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2021, closing a stake of 31,605 shares — an estimated $92K sold.

Dimensional Fund Advisors first reported a position in ODT in Q4 2019 and held it in 6 quarters. The position peaked at $381K in Q2 2020. 50 funds tracked by Wall St. Rank hold ODT as of Q4 2021.

  • Dimensional Fund Advisors reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 31,605 Odonate Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $92K.
  • Dimensional Fund Advisors first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • Dimensional Fund Advisors's Odonate Therapeutics, Inc. Common Stock position peaked at $381K in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Dimensional Fund Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.